Bayer Aktiengesellschaft against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-09-23T15:37:33+00:00 UTC · updates daily
TEVA leads 3 of the 5 windows we measure — over 1 month BAYN.DE is +1.7% and TEVA +5.6%; over year to date BAYN.DE is +33.2% and TEVA +25.0%.
| BAYN.DE | TEVA | |
|---|---|---|
| Price | $49.31 | $39.01 |
| 1 day | -0.5%lead | -1.3% |
| 5 days | +0.7% | +1.2%lead |
| 1 month | +1.7% | +5.6%lead |
| 6 months | +28.2% | +35.6%lead |
| Year to date | +33.2%lead | +25.0% |
| 52-week position | 84% of range | 92% of range |
| 52-week range | $25.78–$53.92 | $18.21–$40.79 |
| vs 50-day average | above $48.45 | above $35.79 |
| vs 200-day average | above $42.54 | above $33.32 |
| RSI (14) | 50 | 59 |
| Next earnings | 2026-11-03 | 2026-11-03 |
BAYN.DE trades at $49.31, above its 50-day average of $48.45, and above the 200-day at $42.54. It sits at 84% of its 52-week range ($25.78–$53.92); 14-day RSI is 50, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $50.00 (1.4% away) and the first support below is $48.45 (1.7% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
TEVA trades at $39.01, above its 50-day average of $35.79, and above the 200-day at $33.32. It sits at 92% of its 52-week range ($18.21–$40.79); 14-day RSI is 59, in neutral territory; an average session moves it about 3.3%. For levels, the first level overhead is $40.00 (2.5% away) and the first support below is $35.79 (8.2% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA is the more volatile of the two — an average session moves it 3.3% against 2.5% for BAYN.DE, so an identical position size carries roughly 1.3× the daily risk.
The comparison turns on those levels: BAYN.DE clearing $50.00 or losing $48.45; TEVA clearing $40.00 or losing $35.79. Until one of them gives way, the relative reading above stands.